Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Low adherence to the guideline for the acute treatment of migraine

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review


  1. Exercise suppresses tumor growth independent of high fat food intake and associated immune dysfunction

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Initial evidence of abnormal brain plasticity in anorexia nervosa: an ultra-high field study

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

The real-world use of triptans in the treatment of migraine is disappointing. Only 12% of the Danish migraine population purchased a triptan between 2014 and 2019, and only 43% repurchased a triptan after first prescription. The aim of the present study was to assess whether physicians and patients adhere to the therapeutic guideline on acute migraine treatment. We interviewed 299 triptan experienced participants with migraine and 101 triptan naïve participants with migraine from the Danish Migraine Population Cohort, using a semi-structured questionnaire. Descriptive statistical analyses were used to study the association with triptan use and the assessed factors. Among triptan naïve participants with migraine, 64% had consulted their general practitioner about their migraine, of whom only 23% received information about the possibility of triptan treatment. Among triptan experienced participants, 77% had only tried one type of triptan. Only 12% could recall they had been informed by their general practitioner to try each triptan three times before giving up. Twenty percent were informed to try three different triptans in total, if the first did not work. In disagreement with the guideline, participants who reported a low pain reduction by a triptan had only tried one type of triptan. Our study shows a low adherence to therapeutic guideline for the attack treatment of migraine. There is a need for better education of general practitioners regarding treatment of migraine. Future campaigns should aim to inform both the public and the general practitioner about antimigraine treatments.

TidsskriftScientific Reports
Udgave nummer1
Sider (fra-til)8487
StatusUdgivet - 19 maj 2022

Bibliografisk note

© 2022. The Author(s).

ID: 78265283